Correction: Kuo and Chang, GATA-1 and Gfi-1B interplay to regulate Bcl-xL transcription [Mol Cell Biol 27, 12, (2007) (4261-4272)]doi 10.1128/MCB.02212-06;GATA-1 and Gfi-1B interplay to regulate Bcl-xL transcription

Molecular and Cellular Biology

Volumn 27, Issue 12, 2007, Pages 4261-4272

  Kuo, Yuan Yeh ^a   Chang, Zee Fen ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC; BCR ABL PROTEIN; GENE PRODUCT; IMATINIB; PROTEIN GFI 1B; TRANSCRIPTION FACTOR GATA 1; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; BCL XL GENE; CELL CULTURE; CELL DEATH; CELL LINE; CELL STRAIN 3T3; CELL SURVIVAL; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ENZYME INHIBITION; ERYTHROID CELL; ERYTHROPOIESIS; GENE; GENE EXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; RAT; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

EID: 34250163897     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00008-17     Document Type: Erratum

References (41)

1. Benito, A., M. Silva, D. Grillot, G. Nunez, and J. L. Fernandez-Luna. 1996. Apoptosis induced by erythroid differentiation of human leukemia cell lines is inhibited by Bcl-XL. Blood 87:3837-3843.
2. de Groot, R. P., J. A. Raaijmakers, J. W. Lammers, and L. Koenderman, 2000. STAT5-dependent cyclin D1 and Bcl-xL expression in Bcr-Abl-transformed cells. Mol. Cell Biol. Res. Commun. 3:299-305.
3. Deininger, M. W., J. M. Goldman, and J. V. Melo. 2000. The molecular biology of chronic myeloid leukemia. Blood 96:3343-3356.
4. Druker, B. J., C. L. Sawyers, H. Kantarjian, D. J. Resta, S. F. Reese, J. M. Ford, R. Capdeville, and M. Talpaz. 2001. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N. Engl. J. Med. 344:1038-1042.
5. Druker, B. J., M. Talpaz, D. J. Resta, B. Peng, E. Buchdunger, J. M. Ford, N. B. Lydon, H. Kantarjian, R. Capdeville, S. Ohno-Jones, and C. L. Sawyers. 2001. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344:1031-1037.
6. Ferrao, P. T., M. J. Frost, S. P. Siah, and L. K. Ashman. 2003. Overexpression of P-glycoprotein in K562 cells does not confer resistance to the growth inhibitory effects of imatinib (STI571) in vitro. Blood 102:4499-4503.
7. Garcon, L., C. Lacout, F. Svinartchouk, J. P. Le Couedic, J. L. Villeval, W. Vainchenker, and D. Dumenil. 2005. Gfi-1B plays a critical role in terminal differentiation of normal and transformed erythroid progenitor cells. Blood 105:1448-1455.
8. Gotoh, A., and H. E. Broxmeyer. 1997. The function of BCR/ABL and related proto-oncogenes. Curr. Opin. Hematol. 4:3-11.
9. Gregory, T., C. Yu, A. Ma, S. H. Orkin, G. A. Blobel, and M. J. Weiss. 1999. GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood 94:87-96.
10. Grillot, D. A., M. Gonzalez-Garcia, D. Ekhterae, L. Duan, N. Inohara, S. Ohta, M. F. Seldin, and G. Nunez. 1997. Genomic organization, promoter region analysis, and chromosome localization of the mouse bcl-x gene. J. Immunol. 158:4750-4757.
11. Grimes, H. L., T. O. Chan, P. A. Zweidler-McKay, B. Tong, and P. N. Tsichlis. 1996. The Gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol. Cell. Biol. 16:6263-6272.
12. Grosveld, F., P. Rodriguez, N. Meier, S. Krpic, F. Pourfarzad, P. Papadopoulos, K. Kolodziej, G. P. Patrinos, A. Hostert, and J. Strouboulis. 2005. Isolation and characterization of hematopoietic transcription factor complexes by in vivo biotinylation tagging and mass spectrometry. Ann. N. Y. Acad. Sci. 1054:55-67.
13. Horita, M., E. J. Andreu, A. Benito, C. Arbona, C. Sanz, I. Benet, F. Prosper, and J. L. Fernandez-Luna. 2000. Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL. J. Exp. Med. 191:977-984.
14. Huang, D. Y., Y. Y. Kuo, and Z. F. Chang. 2005. GATA-1 mediates autoregulation of Gfi-1B transcription in K562 cells. Nucleic Acids Res. 33:5331-5342.
15. Huang, D. Y., Y. Y. Kuo, J. S. Lai, Y. Suzuki, S. Sugano, and Z. F. Chang. 2004. GATA-1 and NF-Y cooperate to mediate erythroid-specific transcription of Gfi-1B gene. Nucleic Acids Res. 32:3935-3946.
16. Jegalian, A. G., and H. Wu. 2002. Regulation of Socs gene expression by the proto-oncoprotein GFI-1B: two routes for STAT5 target gene induction by erythropoietin. J. Biol. Chem. 277:2345-2352.
17. Kantarjian, H., C. Sawyers, A. Hochhaus, F. Guilhot, C. Schiffer, C. Gambacorti-Passerini, D. Niederwieser, D. Resta, R. Capdeville, U. Zoellner, M. Talpaz, B. Druker, J. Goldman, S. G. O'Brien, N. Russell, T. Fischer, O. Ottmann, P. Cony-Makhoul, T. Facon, R. Stone, C. Miller, M. Tallman, R. Brown, M. Schuster, T. Loughran, A. Gratwohl, F. Mandelli, G. Saglio, M. Lazzarino, D. Russo, M. Baccarani, and E. Morra. 2002. Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N. Engl. J. Med. 346:645-652.
18. Kindler, T., F. Breitenbuecher, S. Kasper, T. Stevens, B. Carius, H. Gschaidmeier, C. Huber, and T. Fischer. 200.3. In BCR-ABL-positive cells, STAT-5 tyrosine-phosphorylation integrates signals induced by imatinib mesylate and Ara-C. Leukemia 17:999-1009.
19. Kirchner, D., J. Duyster, O. Ottmann, R. M. Schmid, L. Bergmann, and G. Munzert. 2003. Mechanisms of Bcr-Abl-mediated NF-kappaB/Rel activation. Exp. Hematol. 31:504-511.
20. Mulloy, J. C., J. Cammenga, K. L. MacKenzie, F. J. Berguido, M. A. Moore, and S. D. Nimer. 2002. The AML1-ETO fusion protein promotes the expansion of human hematopoietic stem cells. Blood 99:15-23.
21. Oetzel, C., T. Jonuleit, A. Gotz, H. van der Kuip, H. Michels, J. Duyster, M. Hallek, and W. E. Aulitzky. 2000. The tyrosine kinase inhibitor CGP 57148 (STI 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-X. Clin. Cancer Res. 6:1958-1968.
22. Osawa, M., T. Yamaguchi, Y. Nakamura, S. Kaneko, M. Onodera, K. Sawada, A. Jegalian, H. Wu, H. Nakauchi, and A. Iwaina. 2002. Erythroid expansion mediated by the Gfi-1B zinc linger protein: role in normal hematopoiesis. Blood 100:2769-2777.
23. Reuther, J. Y., G. W. Reuther, D. Cortez, A. M. Pendergast, and A. S. Baldwin, Jr. 1998. A requirement for NF-kappaB activation in Bcr-Abl-mediated transformation. Genes Dev. 12:968-981.
24. Rodriguez, P., E. Bonte, J. Krijgsveld, K. E. Kolodziej, B. Guyot, A. J. Heck, P. Vyas, E. de Boer, F. Grosveld, and J. Strouboulis. 2005. GATA-1 forms distinct activating and repressive complexes in erythroid cells. EMBO J. 24:2354-2366.
25. Saleque, S., S. Cameron, and S. H. Orkin. 2002. The zinc-finger protooncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages. Genes Dev. 16:301-306.
26. Sattler, M., and J. D. Griffin. 2003. Molecular mechanisms of transformation by the BCR-ABL oncogene. Semin. Hemalol. 40(Suppl. 2):4-10.
27. Sawyers, C. L., A. Hochhaus, E. Feldman, J. M. Goldman, C. B. Miller, O. G. Ottmann, C. A. Schiffer, M. Talpaz, F. Guilhot, M. W. Deininger, T. Fischer, S. G. O'Brien, R. M. Stone, C. B. Gambacorti-Passerini, N. H. Russell, J. J. Reiffers, T. C. Shea, B. Chapuis, S. Coutre, S. Tura, E. Morra, R. A. Larson, A. Saven, C. Peschel, A. Gratwohl, F. Mandelli, M. Ben-Am, I. Gathmann, R. Capdeville, R. L. Paquette, and B. J. Druker. 2002. Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase 11 study. Blood 99:3530-3539.
28. Schuh, A. H., A. J. Tipping, A. J. Clark, I. Hamlett, B. Guyot, F. J. Iborra, P. Rodriguez, J. Strouboulis, T. Enver, P. Vyas, and C. Porcher. 2005. ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis. Mol. Cell. Biol. 25:10235-10250.
29. Shim, M. J., H. J. Kim, S. J. Yang, I. S. Lee, H. I. Choi, and T. Kim. 2002. Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: possible involvement of p38 MAP kinase. J. Biochem. Mol. Biol. 35:377-383.
30. Shuai, K., J. Halpern, J. ten Hoeve, X. Rao, and C. L. Sawyers. 1996. Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 13:247-254.
31. Sillaber, C., F. Geshert, D. A. Frank, M. Sattler, and J. D. Griffin. 2000. STAT5 activation contributes to growth and viability in Bcr/Abl-transformed cells. Blood 95:2118-2125.
32. Silva, M., D. Grillot, A. Benito, C. Richard, G. Nunez, and J. L. Fernandez-Luna. 1996. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood 88:1576-1582.
33. Steelman, L. S., S. C. Pohnert, J. G. Shelton, R. A. Franklin, F. E. Bertrand. and J. A. McCubrey. 2004. JAK/STAT, Raf/MEK/ERK, P13K/Akt and BCR-ABL in cell cycle progression and leukemogenesis. Leukemia 18:189-218.
34. Talpaz, M., R. T. Silver, B. J. Druker, J. M. Goldman, C. Gambacorti-Passerini, F. Guilliot, C. A. Schiffer, T. Fischer, M. W. Deininger, A. L. Lennard, A. Hochhaus, O. G. Ottmann, A. Gratwohl, M. Baccarani, R. Stone, S. Tura, F. X. Mahon, S. Fernandes-Reese, I. Gathmann, R. Capdeville, H. M. Kantarjian, and C. L. Sawyers. 2002. Imatinib induces durable hematologic and cytogenetic responses in patients with accelerated phase chronic myeloid leukemia: results of a phase 2 study. Blood 99:1928-1937.
35. Tong, B., H. L. Grimes, T. Y. Yang, S. E. Bear, Z. Qin, K. Du, W. S. El-Deiry, and P. N. Tsichlis. 1998. The Gfi-1B proto-oncoprotein represses p21 WAF1 and inhibits myeloid cell differentiation. Mol. Cell. Biol. 18:2462-2473.
36. Uchida, M., T. Watanabe, M. Kunitama, M. Mori, S. Kikuchi, K. Yoshida, K. Kirito, T. Nagai, K. Ozawa, and N. Komatsu. 2004. Erythropoietin overcomes imatinib-induced apoptosis and induces erythroid differentiation in TF-1/bcr-abl cells. Stem Cells 22:609-616.
37. Vassen, L., K. Fiolka, S. Mahlmann, and T. Moroy. 2005. Direct transcriptional repression of the genes encoding the zinc-finger proteins Gfi1b and Gfi1 by Gfi1b. Nucleic Acids Res. 33:987-998.
38. Weiss, M. J., C. Yu, and S. H. Orkin. 1997. Erythroid-cell- specific properties of transcription factor GATA-1 revealed by phenotypic rescue of a gene-targeted cell line. Mol. Cell. Biol. 17:1642-1651.
39. Welch, J. J., J. A. Watts, C. R. Vakoe, Y. Yao, H. Wang, R. C. Hardison, G. A. Blobel, L. A. Chodosh, and M. J. Weiss. 2004. Global regulation of erythroid gene expression by transcription factor GATA-1. Blood 104:3136-3147.
40. Zhang, P., X. Zhang, A. Iwama, C. Yu, K. A. Smith, B. U. Mueller, S. Narravula, B. E. Torbett, S. H. Orkin, and D. G. Tenen. 2000. PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding. Blood 96:2641-2648.
41. Zweidler-Mckay, P. A., H. L. Grimes, M. M. Flubacher, and P. N. Tsichlis. 1996. Gfi-1 encodes a nuclear zinc finger protein that binds DNA and functions as a transcriptional repressor. Mol. Cell. Biol. 16:4024-4034.